ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 79 filers reported holding ORIC PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $177,000 | -63.5% | 33,100 | +0.3% | 0.00% | – |
| Q4 2021 | $485,000 | -18.1% | 33,000 | +16.6% | 0.00% | – |
| Q3 2021 | $592,000 | +18.2% | 28,300 | 0.0% | 0.00% | – |
| Q2 2021 | $501,000 | -21.1% | 28,300 | +9.3% | 0.00% | – |
| Q1 2021 | $635,000 | -24.3% | 25,900 | +4.4% | 0.00% | – |
| Q4 2020 | $839,000 | +194.4% | 24,800 | +117.5% | 0.00% | – |
| Q3 2020 | $285,000 | -17.2% | 11,400 | +11.8% | 0.00% | – |
| Q2 2020 | $344,000 | – | 10,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $99,703,000 | 11.34% |
| Euclidean Capital LLC | 777,193 | $16,251,000 | 7.90% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $12,594,000 | 7.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $21,068,000 | 5.64% |
| EcoR1 Capital, LLC | 3,468,944 | $72,536,000 | 2.52% |
| EMERALD ADVISERS, LLC | 726,236 | $15,186,000 | 0.55% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 742,666 | $15,529,000 | 0.54% |
| Orbimed Advisors | 2,337,574 | $48,879,000 | 0.54% |
| Casdin Capital, LLC | 601,515 | $12,578,000 | 0.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 53,000 | $1,104,000 | 0.27% |